相关实验视频
Updated: Jul 18, 2025

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.9K
前列腺癌转移中的骨微环境土壤:一种miRNA方法
Anne Natalie Prigol1, Michele Patrícia Rode1, Fernanda da Luz Efe1
1Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, Santa Catarina State, Brazil.
Cancers
|August 26, 2023
概括
微RNA (miRNA) 在前列腺癌 (PCa) 骨转移的发展,诊断和治疗中起着至关重要的作用. 这些分子作为非侵入性生物标志物和治疗点,有望改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 带有骨转移的前列腺癌 (PCa) 是死亡的重要原因.
- 微RNA (miRNA) 表达变化与PCa进展和转移有关.
- 通过影响骨重塑细胞,PCa外基因组有助于转移.
研究的目的:
- 编制miRNAs在骨转移性PCa的发展,诊断和治疗中的作用.
- 审查PCa骨转移中miRNAs的近期体内和体外研究.
- 突出miRNAs作为生物标记物和治疗剂的潜力.
主要方法:
- 在体内和体外研究的文献综述,重点关注PCa骨转移中的miRNAs.
- 对miRNA参与PCa细胞增殖,转移和骨重塑的分析.
- 基于miRNA的诊断和治疗策略的评估.
主要成果:
- 在PCa中异常的miRNA表达促进异常的骨重塑和瘤生长.
- 含有miRNA的PCa外基因组促进转移相关事件.
- miRNAs具有作为治疗工具 (对抗Rs,miRNA模拟器) 和非侵入性生物标志物的潜力.
结论:
- miRNAs是PCa骨转移的发展和进展的关键调节者.
- miRNA表达特征和基于miRNA的工具对于改善患者的寿命和生活质量至关重要.
- miRNAs对于骨转移性PCa的非侵入性诊断和向性治疗具有显著的前景.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K

